AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report 2019 - ResearchAndMarkets.com

March 28, 2019

DUBLIN--(BUSINESS WIRE)--Mar 28, 2019--The “Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polytetrafluoroethylene, Polyurethane, Biological Materials), And Segment Forecasts, 2019 - 2025” report has been added to ResearchAndMarkets.com’s offering.

The global hemodialysis vascular grafts market size is expected to reach USD 276.5 million by 2025, at a CAGR of 4.1% during the forecast period.

Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological access products due to technological advancements in the field are some of the factors contributing to revenue growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for vascular grafts over the forecast period.

The global hemodialysis vascular grafts market, by raw material, was dominated by PTFE grafts with a revenue share of 45.0% in 2018. The segment is anticipated to maintain its position throughout the forecast period. High product penetration, wide availability, and comparatively cheaper products are supplementing the dominance of the segment. Moreover, recent development of biological grafts for hemodialysis is expected to increase its adoption, owing to lower possibility of rejection and infection of these products.

North America dominated the market in 2018 and accounted for approximately 32.0% of the overall revenue. The U.S. is a key revenue contributor not only in the region but at the global marketplace as well. The growth of the market in the country can be attributed to growing number of renal impaired patients undergoing hemodialysis and surging demand for AVGs required to create superficial access for blood transfusion.

Developing economies such as China and India have lower availability of kidney donors as compared to developed economies. Thus patients opt for alternatives such as hemodialysis. Increase in number of hemodialysis procedures is expected to drive the market between 2018 and 2025. Asia Pacific is poised to exhibit a CAGR of 6.6% between 2018 and 2025, owing to increasing number of patients with CKD, growing awareness regarding safety of AVG, and rising healthcare expenditure.

Further Key Findings From the Report Suggest:

  • North America dominated the market in 2017, owing to geightened awareness regarding treatment options available, increasing adoption of hemodialysis access grafts, and technological advancements in AVG
  • Asia Pacific is anticipated to be the fastest growing regional market with a CAGR of 6.6 % between 2018 and 2025
  • Some of the key market players in this market are W.L. Gore & Associates; C. R. Bard, Inc.; Terumo Medical Corporation; LeMaitre Vascular, Inc.; Getinge AB; Vascular Genesis; InnAVasc Medical, Inc.; CryoLife, Inc.; Merit Medical Systems, Inc.; and Proteon Therapeutics, Inc.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Market Variables, Trends& Scope

3.1 Market Segmentation& Scope

3.1.1 Market driver analysis

3.1.1.1 Increase in prevalence of renal disorders

3.1.1.2 Presence of well-defined regulatory guidelines in developed economies

3.1.1.3 Increasing adoption of biological access grafts

3.1.2 Market restraint analysis

3.1.2.1 Low reimbursement rate and high out-of-pocket expenditure in emerging markets

3.1.2.2 Economic pricing for peritoneal dialysis procedures

3.1.2.3 Low diagnosis rate of patients with kidney diseases

3.1.2.4 Increase in number of patients undergoing peritoneal dialysis in developed economies

3.2 Global hemodialysis vascular grafts market - PESTEL Analysis

3.3 Industry Analysis - Porter’s

3.4 Global Hemodialysis Vascular Grafts Market Regulatory Scenario

3.5 Average Selling Price by Product, USD (2014 to 2025)

Chapter 4 Global Hemodialysis Vascular Grafts Market: Raw Material Estimates & Trend Analysis

4.1 Global hemodialysis vascular grafts market: Raw material movement analysis

4.2 Polyester

4.3 Polytetrafluoroethylene

4.4 Polyurethane

4.5 Biological materials

4.5.1 Market, revenue estimates and forecasts, 2014 - 2025 (USD Million)

4.5.2 Human Saphenous and Umbilical Veins

4.5.4 Tissue Engineered Materials

Chapter 5 Hemodialysis Vascular Graft Market: Regional Estimates & Trend Analysis, by Raw Materials

5.1 Global Hemodialysis Vascular Market Share by Region, 2014 & 2025

Chapter 6 Competitive Landscape

6.1 Strategy Framework

6.2 Company Profiles

  • W. L. Gore & Associates.
  • C. R. Bard, Inc.
  • Terumo Medical Corporation.
  • Lemaitre Vascular, Inc.
  • Getinge AB.
  • VASCULAR GENESIS.
  • InnAVasc Medical, Inc.
  • CryoLife, Inc.
  • MERIT MEDICAL SYSTEMS, INC
  • Proteon Therapeutics Inc.

For more information about this report visit https://www.researchandmarkets.com/r/6mjxhi

View source version on businesswire.com:https://www.businesswire.com/news/home/20190328005861/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Devices,Dialysis

KEYWORD:

INDUSTRY KEYWORD: HEALTH CARDIOLOGY MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/28/2019 03:18 PM/DISC: 03/28/2019 03:18 PM

http://www.businesswire.com/news/home/20190328005861/en